Co-Diagnostics, Inc. logo CODX - Co-Diagnostics, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 2
HOLD 3
SELL 0
STRONG
SELL 0
| PRICE TARGET: $180.00 DETAILS
HIGH: $180.00
LOW: $180.00
MEDIAN: $180.00
CONSENSUS: $180.00
UPSIDE: 1470.56%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue 0.6 3.9 6.8 34.2 97.9 74.6 0.2 0.0 0.0 0 0.0 0
Cost of Revenue 0.2 1.0 4.2 5.5 11.6 16.6 0.1 0.0 0.0 0.0 0.0 0
Gross Profit 0.4 2.9 2.6 28.7 86.3 58.0 0.1 0.0 0.0 (0.0) 0.0 0
Operating Expenses
R&D Expenses 19.1 21.0 23.0 17.4 15.0 3.2 1.4 1.4 1.0 0.7 0.8 0.3
SG&A Expenses 11.4 20.6 21.1 21.6 24.9 12.9 4.6 4.7 3.5 0.9 1.1 0.7
Other Expenses 1.1 1.4 1.2 16.7 0.3 0.1 0.1 0.1 0.0 0 0.0 0.0
Operating Expenses 31.7 43.0 45.3 55.7 40.2 16.3 6.0 6.1 4.6 1.7 2.0 1.0
Operating Income
Operating Income (31.3) (40.1) (42.7) (27.0) 46.1 41.7 (5.9) (6.1) (4.6) (1.7) (2.0) (1.0)
Interest Expense 0 0 0 0 0 0 0.1 0.1 0.3 0.2 0.1 0
Interest Income 0.3 1.1 1.2 0.7 0.0 0.1 0.0 0.0 0.0 0 0 0.0
Profitability
EBITDA (30.2) (38.7) (41.5) (10.3) 46.4 41.8 (6.0) (6.1) (6.6) (1.7) (1.9) (1.0)
EBIT (31.3) (40.1) (42.7) (11.6) 46.1 41.7 (6.1) (6.1) (6.6) (1.7) (2.0) (1.0)
Income Before Tax (48.5) (37.6) (38.1) (18.8) 45.6 42.6 (6.2) (6.3) (7.0) (1.9) (2.0) (1.0)
Income Tax Expense (1.6) 0.1 (2.8) (4.6) 9.0 0.1 0 (0.0) 0 0 0 0
Net Income (46.9) (37.6) (35.3) (14.2) 36.7 42.5 (6.2) (6.3) (7.0) (1.9) (2.0) (1.0)
Per Share Data
EPS (Basic) -35.25 -37.20 -36.00 -13.57 38.10 1.59 -11.09 -15.00 -18.90 -5.10 -5.40 -3.90
EPS (Diluted) -35.25 -37.20 -36.00 -13.57 36.90 1.52 -11.09 -15.00 -18.90 -5.10 -5.40 -3.90
Shares Outstanding 1.3 1.0 1.0 1.0 1.0 0.9 0.6 0.4 0.4 0.4 0.4 0.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 11.9 2.9 14.9 23.0 88.6 43.0 0.9 1.0 3.5 1.0
Short-Term Investments 0 26.8 43.6 58.3 1.3 4.3 0 0 0 0
Net Receivables 0.2 0.1 0.3 5.4 20.9 12.1 0.1 0.0 0 0.0
Inventory 1.0 1.1 1.7 5.3 2.0 8.0 0.2 0.0 0.0 0
Other Current Assets 0.6 0 1.6 0 0 0.5 0 0 0 0
Total Current Assets 13.7 32.3 62.1 92.7 115.1 68.4 1.6 1.1 4.5 1.2
Non-Current Assets
Property, Plant & Equipment 3.5 4.9 6.0 2.9 1.9 0.9 0.2 0.2 0.2 0.1
Goodwill 0 0 0 0 14.7 0 0 0 0 0
Intangible Assets 7.2 26.1 26.4 26.8 27.2 0 0 0 0 0
Long-Term Investments 0.4 0.7 0.8 0.7 1.0 1.9 0.4 0.3 0.0 0
Other Non-Current Assets 0 0 0 0 0.1 0 0 0 0 0
Total Non-Current Assets 11.0 31.7 33.2 30.4 44.9 2.9 0.6 0.5 0.2 0.1
Total Assets 24.7 64.0 95.3 123.1 160.0 71.2 2.2 1.6 4.7 1.3
Current Liabilities
Account Payables 1.9 3.3 1.5 1.0 0.6 0.6 0.0 0.1 0.0 0.1
Short-Term Debt 0.7 0 0 0 0 0 0 1.9 0 2.9
Deferred Revenue 0.0 0 0.4 0 0.1 0.3 0.0 0 0.0 0
Other Current Liabilities 1.0 0.5 1.4 1.7 5.8 0 0 0 0 0
Total Current Liabilities 3.5 7.3 5.7 3.9 12.6 4.1 0.3 2.4 0.6 3.8
Non-Current Liabilities
Long-Term Debt 0.6 0 0 0 0 0 0 0 0 0.4
Deferred Tax Liabilities 0 0 0 2.4 7.2 0 0 0 0 0
Other Non-Current Liabilities 0 1.1 1.4 2.2 5.7 0.5 0.1 0.3 0 0
Total Non-Current Liabilities 0.6 2.4 3.6 4.7 13.0 0.5 0.1 0.3 0.2 0.4
Total Liabilities 4.1 9.7 9.3 8.6 25.6 4.5 0.5 2.6 0.8 4.3
Stockholders' Equity
Common Stock 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (80.4) (33.0) 4.6 39.9 54.2 17.5 (25.0) (18.7) (12.4) (5.5)
Accumulated Other Comprehensive Income 0 0.4 0.1 0.3 0 0 0 0 0 0
Total Stockholders' Equity 20.6 54.3 86.0 114.5 134.5 66.7 1.7 (1.1) 3.9 (3.0)
Total Liabilities & Equity 24.7 64.0 95.3 123.1 160.0 71.2 2.2 1.6 4.7 1.3
Debt Metrics
Total Debt 1.2 2.2 3.0 0.3 0 0 0 1.9 0 3.4
Net Debt (10.6) (0.8) (11.9) (22.6) (88.6) (43.0) (0.9) 1.0 (3.5) 2.4
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (46.9) (37.6) (35.3) (14.2) 36.7 42.5 (6.2) (6.3) (7.0) (1.9)
Depreciation & Amortization 1.1 1.4 1.2 1.3 0.3 0.1 0.1 0.1 0.0 0.0
Stock-Based Compensation 2.2 5.4 8.3 7.5 5.5 2.7 1.1 1.3 2.0 0.1
Change in Working Capital (3.2) 2.8 5.6 6.2 (2.9) (16.8) (0.8) 0.8 (0.5) 0.5
Other Non-Cash Items 17.6 (1.1) 0.5 10.6 0.5 0.2 0.1 0.0 2.2 0.0
Operating Cash Flow (29.1) (29.2) (22.1) 6.6 41.1 28.2 (5.5) (4.1) (3.2) (1.3)
Investing Activities
Capital Expenditure (0.7) (0.7) (1.4) (1.4) (0.7) (0.8) (0.1) (0.0) (0.1) (0.0)
Acquisitions (0.1) (0.1) 0 0 1.7 (0.7) (0.3) 0 0 0
Purchases of Investments (6.6) (40.8) (110.5) (68.0) 0 (9.3) (0.3) (0.3) (0.1) 0
Sales/Maturities of Investments 33.7 58.8 127.3 11.3 3.1 5.0 0.6 0 0 0
Other Investing Activities 0 0 0 0 0 0 (0.3) 0 0 0
Investing Cash Flow 26.3 17.1 15.4 (58.2) 4.1 (5.8) (0.4) (0.4) (0.2) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 2 (0.0) 2.3
Stock Repurchased 0 0 (1.4) (14.2) 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0.2 0 0.3 (0.6) (0.2) (1.1) 0
Financing Cash Flow 11.8 0.1 (1.4) (14.0) 0.5 19.7 5.9 1.9 5.9 2.3
Cash Position
Net Change in Cash 8.9 (12.0) (8.1) (65.6) 45.6 42.1 (0.1) (2.6) 2.5 1.0
Cash at Beginning 2.9 14.9 23.0 88.6 43.0 0.9 1.0 3.5 1.0 0.0
Cash at End 11.9 2.9 14.9 23.0 88.6 43.0 0.9 1.0 3.5 1.0
Free Cash Flow (29.8) (29.9) (23.4) 5.1 40.4 27.4 (5.6) (4.1) (3.3) (1.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Income Statement
Revenue 0.6 3.9 6.8 34.2 97.9 74.6 0.2 0.0 0.0 0 0.0 0
Gross Profit 0.4 2.9 2.6 28.7 86.3 58.0 0.1 0.0 0.0 (0.0) 0.0 0
Operating Income (31.3) (40.1) (42.7) (27.0) 46.1 41.7 (5.9) (6.1) (4.6) (1.7) (2.0) (1.0)
Net Income (46.9) (37.6) (35.3) (14.2) 36.7 42.5 (6.2) (6.3) (7.0) (1.9) (2.0) (1.0)
EPS (Diluted) -35.25 -37.20 -36.00 -13.57 36.90 1.52 -11.09 -15.00 -18.90 -5.10 -5.40 -3.90
Balance Sheet
Cash & Equivalents 11.9 2.9 14.9 23.0 88.6 43.0 0.9 1.0 3.5 1.0
Total Assets 24.7 64.0 95.3 123.1 160.0 71.2 2.2 1.6 4.7 1.3
Total Debt 1.2 2.2 3.0 0.3 0 0 0 1.9 0 3.4
Stockholders' Equity 20.6 54.3 86.0 114.5 134.5 66.7 1.7 (1.1) 3.9 (3.0)
Cash Flow
Operating Cash Flow (29.1) (29.2) (22.1) 6.6 41.1 28.2 (5.5) (4.1) (3.2) (1.3)
Capital Expenditure (0.7) (0.7) (1.4) (1.4) (0.7) (0.8) (0.1) (0.0) (0.1) (0.0)
Free Cash Flow (29.8) (29.9) (23.4) 5.1 40.4 27.4 (5.6) (4.1) (3.3) (1.3)